These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19430509)
1. [Outpatient treatment of deep vein thrombosis: comparative study with historical inpatients]. Alonso JL; Abinzano ML; Urbieta MA; Anniccherico FJ An Sist Sanit Navar; 2009; 32(1):35-42. PubMed ID: 19430509 [TBL] [Abstract][Full Text] [Related]
2. Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis. Boucher M; Rodger M; Johnson JA; Tierney M Pharmacotherapy; 2003 Mar; 23(3):301-9. PubMed ID: 12627927 [TBL] [Abstract][Full Text] [Related]
3. Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants. Porath AD; Clodfelter S; Slaton T; Bookhart BK; Kozma CM; Rand ML; Bloch MJ Clin Ther; 2019 Feb; 41(2):269-279. PubMed ID: 30642614 [TBL] [Abstract][Full Text] [Related]
4. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611 [TBL] [Abstract][Full Text] [Related]
5. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting. Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Tillman DJ; Charland SL; Witt DM Arch Intern Med; 2000 Oct; 160(19):2926-32. PubMed ID: 11041899 [TBL] [Abstract][Full Text] [Related]
7. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice. Zidane M; van Hulsteijn LH; Brenninkmeijer BJ; Huisman MV Haematologica; 2006 Aug; 91(8):1052-8. PubMed ID: 16885045 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Boccalon H; Elias A; Chalé JJ; Cadène A; Gabriel S Arch Intern Med; 2000 Jun; 160(12):1769-73. PubMed ID: 10871969 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial. Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U; J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787 [TBL] [Abstract][Full Text] [Related]
11. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program. Groce JB Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912 [TBL] [Abstract][Full Text] [Related]
12. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Huse DM; Cummins G; Taylor DC; Russell MW Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346 [TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis. Weeda ER; Butt S Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):301S-313S. PubMed ID: 30428693 [TBL] [Abstract][Full Text] [Related]
14. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Hansson PO; Sörbo J; Eriksson H Arch Intern Med; 2000 Mar; 160(6):769-74. PubMed ID: 10737276 [TBL] [Abstract][Full Text] [Related]
15. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients. Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562 [TBL] [Abstract][Full Text] [Related]
16. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267 [TBL] [Abstract][Full Text] [Related]
17. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries. Amin AN; Lin J; Thompson S; Wiederkehr D Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717 [TBL] [Abstract][Full Text] [Related]
18. Underutilization of Thrombolytic Therapy for Patients Diagnosed with Acute Deep Venous Thrombosis in the Outpatient Setting. Archie M; Archie M; O'Connell J; DeRubertis BG Ann Vasc Surg; 2018 May; 49():255-260. PubMed ID: 29499353 [TBL] [Abstract][Full Text] [Related]